Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Perrigo
Perrigo
Activities:
Ingredients
Pharmaceutical
Dietary supplements
Active Nutrition
Food
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Catalent client gets FDA approval for generic bronchodilator
Approval has marked the first generic metered-dose inhaler to be approved by the FDA in over twenty years and will now be scaled-up
Media
Hikma enters into licensing partnership with Perrigo in MENA
The partnership will provide significant collaboration opportunity
Finance
Mylan fails in US$26bn hostile takeover bid for Perrigo
Not enough shareholders supported the deal
Analysis
Operational cost savings for Perrigo UK
SP-4C weight checkers replace a manual sampling system
Finance
Perrigo to acquire OTC brands from GSK
In the areas of nicotine replacement therapy, cold and flu, and cold sore management
Drug Delivery
Perrigo acquires Patheon's Mexican operations for US$34m
Strengthening its capabilities with the addition of softgel manufacturing technology
Finance
Perrigo Board unanimously rejects unsolicited US$29bn bid from Mylan
Says it substantially undervalues the company and ignores key factors
Subscribe now